TrialThe oncologist2020

A Phase II Study of Perioperative Capecitabine plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).

Tetsuji Terazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.